Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Genovate Biotechnology Co., Ltd. (4130.TWO)

Compare
20.25
-0.25
(-1.22%)
At close: 1:30:36 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Zheng Chen Ph.D. Chairman & CSO -- -- 1953
Chia-Chen Chu General Manager & Director -- -- --
Ming Gui Peng Deputy General Manager of Operations -- -- --

Genovate Biotechnology Co., Ltd.

No. 1, Gongye 1st Road
Hsinchu Industrial Zone Hukou Township
Hsinchu City, 30351
Taiwan
886 3 598 2221 https://www.genovate-bio.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
195

Description

Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan. It provides drugs, APIs, intermediates, and release agents for the treatment of cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune diseases; and controlled-release dosage forms of Western medicine, as well as cosmetics. The company was founded in 1982 and is based in Hsinchu City, Taiwan.

Corporate Governance

Genovate Biotechnology Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 21, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers